Literature DB >> 19515286

An update on brain stimulation for epilepsy.

Christopher Todd Anderson1, Kathryn Davis, Gordon Baltuch.   

Abstract

Brain stimulation for epilepsy has been explored for decades. Nevertheless, this area has traditionally been associated with small poorly controlled trials, inconsistent results, and a resultant lack of widespread use of these technologies. Due to the success of deep brain stimulation for movement disorders and unprecedented advances in computer technology and bioengineering, brain stimulation recently has again generated great interest in epilepsy care. Several large-scale, randomized, blinded, multicenter trials have been conducted; the most up-to-date findings are summarized in this article. These treatment modalities will likely improve over time. The hope that they provide to patients with refractory epilepsy cannot be underestimated.

Entities:  

Mesh:

Year:  2009        PMID: 19515286     DOI: 10.1007/s11910-009-0049-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  18 in total

1.  Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy.

Authors:  Joshua Rosenow; Kaushik Das; Richard L Rovit; William T Couldwell
Journal:  Stereotact Funct Neurosurg       Date:  2002       Impact factor: 1.875

2.  High frequency thalamic stimulation for inoperable mesial temporal epilepsy.

Authors:  Ivan Osorio; John Overman; Jonathon Giftakis; Steven B Wilkinson
Journal:  Epilepsia       Date:  2007-03-26       Impact factor: 5.864

3.  Postmortem study of deep brain stimulation of the anterior thalamus: case report.

Authors:  Julie G Pilitsis; Yaping Chu; Jeffrey Kordower; Donna C Bergen; Elizabeth J Cochran; Roy A E Bakay
Journal:  Neurosurgery       Date:  2008-02       Impact factor: 4.654

Review 4.  Evaluating devices for treating epilepsy.

Authors:  Brian Litt
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

Review 5.  Responsive cortical stimulation for the treatment of epilepsy.

Authors:  Felice T Sun; Martha J Morrell; Robert E Wharen
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

6.  Deep brain stimulation in patients with refractory temporal lobe epilepsy.

Authors:  Paul Boon; Kristl Vonck; Veerle De Herdt; Annelies Van Dycke; Maarten Goethals; Lut Goossens; Michel Van Zandijcke; Tim De Smedt; Isabelle Dewaele; Rik Achten; Wytse Wadman; Frank Dewaele; Jacques Caemaert; Dirk Van Roost
Journal:  Epilepsia       Date:  2007-08       Impact factor: 5.864

7.  Hippocampal electrical stimulation in mesial temporal lobe epilepsy.

Authors:  J F Tellez-Zenteno; R S McLachlan; A Parrent; C S Kubu; S Wiebe
Journal:  Neurology       Date:  2006-03-22       Impact factor: 9.910

8.  Electrical stimulation of the hippocampal epileptic foci for seizure control: a double-blind, long-term follow-up study.

Authors:  Ana Luisa Velasco; Francisco Velasco; Marcos Velasco; David Trejo; Guillermo Castro; José Damián Carrillo-Ruiz
Journal:  Epilepsia       Date:  2007-07-18       Impact factor: 5.864

9.  Chronic anterior thalamus stimulation for intractable epilepsy.

Authors:  Mojgan Hodaie; Richard A Wennberg; Jonathan O Dostrovsky; Andres M Lozano
Journal:  Epilepsia       Date:  2002-06       Impact factor: 5.864

View more
  3 in total

Review 1.  Rescue therapies for seizures.

Authors:  Valeriya S Poukas; John R Pollard; Christopher Todd Anderson
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

2.  Epilepsy surgery: factors that affect patient decision-making in choosing or deferring a procedure.

Authors:  Christopher Todd Anderson; Eva Noble; Ram Mani; Kathy Lawler; John R Pollard
Journal:  Epilepsy Res Treat       Date:  2013-09-16

3.  Long-term music adjuvant therapy enhances the efficacy of sub-dose antiepileptic drugs in temporal lobe epilepsy.

Authors:  Ceng-Lin Xu; Jia-Zhen Nao; Yu-Jia Shen; Yi-Wei Gong; Bei Tan; Shuo Zhang; Ke-Xin Shen; Cui-Rong Sun; Yi Wang; Zhong Chen
Journal:  CNS Neurosci Ther       Date:  2021-02-28       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.